DE FALCO, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 1.124
EU - Europa 909
AS - Asia 905
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 31
OC - Oceania 3
Totale 3.210
Nazione #
US - Stati Uniti d'America 1.087
SG - Singapore 427
IT - Italia 279
IE - Irlanda 151
CN - Cina 120
HK - Hong Kong 111
BR - Brasile 103
RU - Federazione Russa 89
DE - Germania 82
VN - Vietnam 79
FI - Finlandia 46
SE - Svezia 43
KR - Corea 41
FR - Francia 39
RO - Romania 38
BD - Bangladesh 34
UA - Ucraina 31
GB - Regno Unito 27
IN - India 21
CA - Canada 20
TR - Turchia 18
NL - Olanda 15
PL - Polonia 13
AR - Argentina 12
BE - Belgio 11
MX - Messico 10
AT - Austria 9
CZ - Repubblica Ceca 9
ES - Italia 9
PK - Pakistan 7
IQ - Iraq 6
JP - Giappone 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CH - Svizzera 5
CI - Costa d'Avorio 5
EC - Ecuador 5
LT - Lituania 5
MA - Marocco 5
CO - Colombia 4
VE - Venezuela 4
AZ - Azerbaigian 3
EG - Egitto 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CL - Cile 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
LB - Libano 2
NG - Nigeria 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 3.107
Città #
Singapore 317
Chandler 158
Dublin 151
Perugia 132
San Jose 125
Hong Kong 110
Ashburn 78
San Mateo 57
Munich 49
Boardman 45
Santa Clara 44
Seoul 41
Bucharest 33
New York 31
Los Angeles 30
Moscow 29
Altamura 26
Lauterbourg 26
Turku 25
Beijing 24
Dong Ket 24
Ho Chi Minh City 21
Wilmington 17
Council Bluffs 16
Piscataway 16
The Dalles 16
Ann Arbor 15
Helsinki 15
Lawrence 15
Medford 15
Princeton 15
Warsaw 12
Brussels 11
Hanoi 11
São Paulo 11
Jacksonville 10
Andover 9
Assisi 9
Dallas 9
Falls Church 8
Frankfurt am Main 8
Hefei 8
Izmir 8
Amsterdam 7
Brooklyn 7
Milan 7
Rome 7
Stockholm 7
Toronto 7
Vienna 7
Chennai 6
Foligno 6
Mexico City 6
Tashkent 6
Tokyo 6
Abidjan 5
Ankara 5
Barnet 5
Dearborn 5
Houston 5
Johannesburg 5
Montreal 5
Nuremberg 5
Olomouc 5
Bastia 4
Brno 4
Collazzone 4
London 4
Manchester 4
Mumbai 4
Phoenix 4
Poplar 4
Rio de Janeiro 4
Shanghai 4
Atlanta 3
Belo Horizonte 3
Biên Hòa 3
Buffalo 3
Cairo 3
Charlotte 3
Chicago 3
Columbus 3
Curitiba 3
Denver 3
Dhaka 3
Guangzhou 3
Hải Dương 3
Istanbul 3
Madrid 3
Naples 3
Orem 3
Rio Grande 3
San Francisco 3
San Paolo di Civitate 3
Ancona 2
Baghdad 2
Baku 2
Bengaluru 2
Bhubaneswar 2
Bologna 2
Totale 2.066
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 183
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 180
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 163
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 144
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 138
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 134
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 132
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 131
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 129
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 128
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 122
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 118
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 116
Cocaine Addiction Treatment and Home Remedies: Use of the Scopolamine Transdermal Patch 109
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 100
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 96
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 95
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 93
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 92
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 91
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 89
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia 82
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 79
Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies 76
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 74
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 71
Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia 56
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 52
Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice 35
Totale 3.210
Categoria #
all - tutte 14.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022258 0 55 3 7 9 6 4 35 12 35 37 55
2022/2023456 17 75 0 62 50 31 11 25 160 0 19 6
2023/2024266 10 33 11 18 0 14 77 4 15 12 30 42
2024/2025639 29 50 16 38 61 53 51 47 106 24 101 63
2025/20261.241 84 73 56 154 194 135 183 68 116 98 39 41
2026/202759 28 31 0 0 0 0 0 0 0 0 0 0
Totale 3.210